Madrona Financial Services »

Lineage Cell Therapeutics In shares owned by Madrona Financial Services

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Madrona Financial Services from 13F filings

Historical chart of Madrona Financial Services investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Madrona Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Madrona Financial Services

Quarter filed Position value Share count Share price at filing
2024-03-31 $22k 15k 1.48
2023-12-31 $16k 15k 1.09

More positions owned by Madrona Financial Services

First Tr Exchange-traded Dorsey Wrt 5 Etf (FV)
Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Pacer Fds Tr Pacer Us Small (CALF)
Blackrock Etf Trust Us Eqt Factor (DYNF)
First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
Vanguard Bd Index Fds Long Term Bond (BLV)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Apple (AAPL)
Northern Lts Fd Tr Iv Main Buywrite (BUYW)
Pacer Fds Tr Developed Mrkt (ICOW)

View all positions for Madrona Financial Services

Top funds holding Lineage Cell Therapeutics In

Vanguard Group
Defender Capital
Raffles Associates
Prescott General Partners
MAI Wealth Advisors
Jpmorgan Chase & Co
Citadel Advisors
Laurion Capital Management
Charles Schwab Investment Management
Bank of New York Mellon
Long Focus Capital Management
Barclays
Royal Bank of Canada
Squarepoint Ops
Jane Street

View all funds holding Lineage Cell Therapeutics In